Skip to main content
. Author manuscript; available in PMC: 2009 Feb 8.
Published in final edited form as: Brain Res. 2007 Dec 5;1193:1–11. doi: 10.1016/j.brainres.2007.11.055

Figure 7.

Figure 7

Figure 7

Egr1 in vitro interacts with the putative Egr1 binding motif on the DBH promoter. (A) 32P-labeled DBH Egr1 double-stranded oligonucleotide (−243/−210) was incubated with nuclear extract from pCMV Egr1-transfected cells alone (lane 2), with 100 × excess unlabeled double-stranded oligonucleotide (lane 3), or with 4- or 2 μg specific Egr1 antibody (lanes 4 and 5). Lane 1 is the labeled DBH Egr1 oligonucleotide alone. Bands are indicated by * to show the displacement of the bands by Egr1 antibody. (B) 32P-labeled double-stranded consensus Egr1 oligonucleotide was incubated with nuclear extracts from pCMV Egr1-transfected cells alone (lane 2), with 100 × excess unlabeled double-stranded consensus oligonucleotide (lane 3), with 100 × excess unlabeled double-stranded mutated consensus Egr1 oligonucleotide (lane 4), or with 700 × excess unlabeled double-stranded DBH Egr1 oligonucleotide (−243/−210) (lane 5). Lane 1 is the labeled consensus Egr1 oligonucleotide alone. Bands are indicated by * to show the displacement by consensus Egr1 and DBH Egr1 oligonucleotides (−243/−210), but not by the oligonucleotide with mutated Egr1. Right panel is the amplified image of the representative gel.